Purchase Order HHSN272201700122P
Award Date 11/1/16
Potential Completion Date 12/30/16
Potential Value $9.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to DNA Twopointo Inc. (doing business as ATUM Biosciences) was made by the Northeast Area of the U.S. government agency on August 3, 2015 for DNA-related services. The $10,800 firm-fixed-price purchase order has a completion date of September 30, 2015 and was not set aside for any specific business type. DNA Twopointo Inc. has previously performed as both a prime and subcontractor on other federal awards with the National Institute of Allergy and Infectious...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to DNA Twopointo Inc. (doing business as ATUM Biosciences) for gene card and gene synthesis services. The contract has a ceiling value of $9,500.00 and was awarded on November 15, 2011 with a final completion date of September 30, 2012. The contract is not set aside for any specific business category. DNA Twopointo Inc....
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $375,000.00 sole source contract to DNA Twopointo Inc., doing business as ATUM Biosciences, for a license to use ATUM's proprietary cell line technology for the production of an engineered antibody (PGDM1400.LS) to support ongoing AIDS clinical trials. The contract has a one-year base period starting May 14, 2023, with four one-year option periods extending to May 13, 2028. There is no set-aside...
- This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to O.d.260, Inc., a for-profit Subchapter S Corporation, for Adenoviral (adenovirus) amplification, purification, and titer determination services. The contract has a ceiling value of $7,636.00 and a completion date of December 21, 2018. This award does not appear to be associated with a larger contract...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $70,000.00 Firm Fixed Price Purchase Order to Bioautomation Corporation for the delivery of a DNA Synthesizer/Bioauto system. The contract has a completion date of September 22, 2014 and was awarded on August 21, 2014. This award does not utilize a set-aside designation. As the NIAID is focused on biomedical and infectious disease research, this DNA synthesis equipment is...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, MD. The contract is for $151,620.00 and covers site-directed mutagenesis, gene synthesis, and plasmid preparation services in support of COVID-19 research. The contract was awarded on a sole-source basis pursuant to FAR...
- The National Institute of Allergy and Infectious Diseases awarded a $149,959.70 firm fixed-price purchase order to Geneuniversal Inc. on September 8, 2021, for gene synthesis, site-directed mutagenesis, PCR cloning, and plasmid preparation services. The contract, with an ultimate completion date of September 7, 2022, was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026...